Covid19 Virus Infection Clinical Trial
— BRAVEOfficial title:
Building Resiliency and Vital Equity (BRAVE) Project: Understanding Native Americans' Perceptions/Beliefs About COVID-19 Testing and Vaccination Study
The Building Resilience and Vital Equity (BRAVE) project seeks to partner with American Indian tribal communities in North Carolina to establish COVID-19 services and resources for American Indian communities. The goal of this study is to 1) understand the barriers and social implications of COVID19 testing and vaccination among American Indians by designing and implementing culturally sensitive survey tools and intervention materials; 2) Implement BRAVE outreach and testing interventions to increase testing in American Indian communities; 3) analyze data and share back with tribal communities to improve perceptions of COVID-19 testing in the AI community and decrease in vaccine hesitancy.
Status | Recruiting |
Enrollment | 4000 |
Est. completion date | June 30, 2022 |
Est. primary completion date | March 30, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Self reports as Native American or American Indian Exclusion Criteria: - Does not self-report as Native American or American Indian |
Country | Name | City | State |
---|---|---|---|
United States | Lumbee Tribe Tribal Housing Complex | Pembroke | North Carolina |
Lead Sponsor | Collaborator |
---|---|
North Carolina Central University | Lumbee Tribe of North Carolina, University of North Carolina at Pembroke |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Increase in COVID-19 testing | Survey responses to determine if participants in zipcodes selected for intervention are more less inclined to get tested for COVID-19. | 1 month | |
Primary | Increase in COVID-19 vaccination | Survey responses to determine if participants in zipcodes selected for intervention are more less inclined to get vaccinated against COVID-19. | 1 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05087225 -
Suspicion of Hypoglycemic Effect of mRNA Based Covid-19 Vaccines (Polyethylene Glycol) Will Happen , Observational Study on Diabetic Patients at Saudia Arabia
|
||
Recruiting |
NCT04790240 -
Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)
|
Phase 1/Phase 2 |